Business Description
Appili Therapeutics is a Canadian company focused on finding and developing new treatments for infectious diseases that currently lack effective solutions. Their pipeline includes three key products: a child-friendly liquid form of the antibiotic metronidazole, a topical skin treatment for a parasitic disease called cutaneous leishmaniasis, and a vaccine targeting a rare but serious bacterial infection known as tularensis. Founded in 2015 and based in Halifax, the company works to address critical gaps in how infectious diseases are treated today.
